Role of etiological therapy in achieving recompensation of decompensated liver cirrhosis

doi:10.4254/wjh.v17.i4.105127

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=0

Apr 27, 2025 (publication date) through Apr 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Apr 27, 2025; 17(4): 105127
Published online Apr 27, 2025. doi: 10.4254/wjh.v17.i4.105127

Role of etiological therapy in achieving recompensation of decompensated liver cirrhosis

Dmitry V Garbuzenko

Dmitry V Garbuzenko, Department of Faculty Surgery, South Ural State Medical University, Chelyabinsk 454092, Russia

Author contributions: Garbuzenko DV contributed to the conception, design, acquisition, analysis, interpretation of data, wrote the manuscript and approved the final version.

Conflict-of-interest statement: Author has no conflict of interest to declare.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Dmitry V Garbuzenko, MD, PhD, Professor, Department of Faculty Surgery, South Ural State Medical University, 64 Vorovskogo Street, Chelyabinsk 454092, Russia. garb@inbox.ru

Received: January 13, 2025
Revised: March 22, 2025
Accepted: April 9, 2025
Published online: April 27, 2025
Processing time: 102 Days and 19.4 Hours

Core Tip

Core Tip: Numerous publications in recent years have shown the efficacy of etiological therapy in achieving recompensation of decompensated liver cirrhosis (LC). The criteria for the recompensation of alcohol-related, as well as hepatitis B virus-related and hepatitis C virus-related decompensated LC were developed at the Baveno VII consensus workshop. This review provides up-to-date information on the role of etiological therapy in achieving recompensation of decompensated LC according to these criteria.